Copyright
©The Author(s) 2017.
World J Cardiol. Feb 26, 2017; 9(2): 109-133
Published online Feb 26, 2017. doi: 10.4330/wjc.v9.i2.109
Published online Feb 26, 2017. doi: 10.4330/wjc.v9.i2.109
Ref. | Year | n | IMH CMR method | Main findings | CMR time post MI | Mean/median F/U CMR |
Carrick et al[74] | 2016 | 245 | T2* | IMH strongest IP for LVR. IMH associated with lower LVEF and greater volumes | 3 d | 7 mo |
Kidambi et al[115] | 2013 | 39 | T2w-TSE and T2* | IMH associated with attenuation of follow-up infarct strain | 3 d | 3 mo |
Husser et al[33] | 2012 | 304 | T2w-TSE | IMH strongest IP for LVR in model with LVEF, IS, LV vol, L-MVO | 6 d | 189 d |
Mather et al[131] | 2011 | 48 | T2w-TSE and T2* | IMH strongest IP of LVR in model with IS, LVEF, LVESV, E-MVO, MSI | 2 d | 3 mo |
Beek et al[24] | 2010 | 45 | T2w-TSE | IMH was a univariate predictor of LVEF. However no prognostic significance beyond baseline LVEF and MVO in predicting final LVEF | 5 d | 4 mo |
Bekkers et al[121] | 2010 | 90 | T2w-TSE | Acute MSI and LVEF increase at follow-up lowest if IMH present. But IMH no prognostic significance beyond MVO in predicting LVEF | 5 d | 103 d |
O’Regan et al[126] | 2010 | 50 | T2* | IMH presence univariate predictor of LVEF and LV volumes. However only IS independently predicted LVEF | 3 d | N/A |
Ganame et al[25] | 2009 | 98 | T2w-TSE | IMH extent strongest IP of LVR in model with IS, E-MVO, Troponin-I, AAR, TTR, IS | 2 d | 4 mo |
- Citation: Khan JN, McCann GP. Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction. World J Cardiol 2017; 9(2): 109-133
- URL: https://www.wjgnet.com/1949-8462/full/v9/i2/109.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i2.109